What is insider trading data?

Insider trading data comes from SEC Form 4 filings, which corporate insiders must file within 2 business days of buying or selling company stock. This includes CEOs, CFOs, directors, and major shareholders.

How do I track congressional stock trades?

InsiderStreet.ai aggregates financial disclosures from the STOCK Act, showing stock trades by members of Congress. These are typically disclosed within 45 days of the transaction.

What are 13F filings?

13F filings are quarterly reports that institutional investment managers with over $100 million in assets must file with the SEC, revealing their equity holdings.

KTTA - Pasithea Therapeutics Corp.

Name: Pasithea Therapeutics Corp. (KTTA) Financial Data
Creator: InsiderStreet.ai
License: https://insiderstreet.ai/terms

$0.80

+0.01 (+1.91%)

After Hours: $0.76 (-0.04, -4.64%)

NASDAQ · Healthcare · Biotechnology · $5.9M · Alpha Radar Neutral · Power 51

Smart Money Score

Watch 25

Insider—

Congress—

ETF Holdings—

Key Statistics

Market Cap$5.9M

52W Range0.281-3.79

Volume190,424

Avg Volume179,591

Beta0.20

Dividend—

Analyst Ratings

1 Buy 0 Hold 0 Sell

Consensus Buy

Company Info

CEOTiago Reis Marques

Employees4

SectorHealthcare

IndustryBiotechnology

IPO Date2021-09-15

Websitepasithea.com

1111 Lincoln Road
Miami Beach, FL 33139
US

702 514 4174

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Latest News

Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript

SeekingAlpha · 3w ago

Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines

GlobeNewsWire · 9w ago

Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock

Bullish GlobeNewsWire · 15w ago

Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock

Bullish GlobeNewsWire · 16w ago

Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS

GlobeNewsWire · 16w ago

Recent Insider Trades

Name	Type	Shares	Price	Date
Dumesnil Simon	P-Purchase	33,333	$0.75	2025-11-28
Leahy Emer	A-Award	33,333	$0.75	2025-11-28
STEINMAN LAWRENCE	P-Purchase	133,333	$0.75	2025-11-28
Schneiderman Daniel	A-Award	26,667	$0.75	2025-11-28
Marques Tiago	P-Purchase	33,333	$0.75	2025-11-28

KTTA

Recent Insider Trades

Sign in to InsiderStreet